1. Home
  2. GME vs AXSM Comparison

GME vs AXSM Comparison

Compare GME & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$17.88

Market Cap

10.7B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$208.59

Market Cap

11.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
AXSM
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electronics Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
11.2B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
GME
AXSM
Price
$17.88
$208.59
Analyst Decision
Sell
Strong Buy
Analyst Count
1
17
Target Price
$13.50
$211.12
AVG Volume (30 Days)
6.7M
645.1K
Earning Date
06-09-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
133.33
38.56
EPS
0.66
N/A
Revenue
$3,629,900,000.00
N/A
Revenue This Year
$18.98
$57.24
Revenue Next Year
N/A
$55.88
P/E Ratio
$27.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.79
$112.90
52 Week High
$28.10
$260.19

Technical Indicators

Market Signals
Indicator
GME
AXSM
Relative Strength Index (RSI) 28.47 34.83
Support Level N/A $179.00
Resistance Level $22.14 $222.93
Average True Range (ATR) 0.36 6.87
MACD 0.02 -0.45
Stochastic Oscillator 10.16 18.80

Price Performance

Historical Comparison
GME
AXSM

About GME GameStop Corporation

GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: